On the one hand, cachexia (driven by the tumor and host immune response) clearly induces changes in the microbiome, e.g., IL-6 transgenic mice develop cachexia and concurrently exhibit altered gut microbiota, implying the host inflammatory environment shapes the microbiome [26,76]. The gene discussed is IL6; the disease is neoplasm.